What's breaking now, across thousands of outlets.
Experts warn that the new drug might be beckoning a new wave of the country’s opioid crisis.
We haven't written up this one. Newsweek has the full story — the link below goes straight to it.
Living in a disadvantaged neighbourhood may be linked to poorer brain health, with researchers finding higher brain age, lower total brain volume and more signs of vascular damage in people living in…
In a study analyzing nearly 3,000 brain MRI exams, researchers found that living in highly disadvantaged neighborhoods was associated with adverse brain health.
First teased in June and formally announced Tuesday as part of “Operation Trialblazer,” the program will partner drugmakers with research institutions to more quickly bring drugs into human testing.
It’s been a little more than a year since Omada Health went public, and the company reported its first profitable quarter this spring. Now, it's preparing for its first CEO transition.
This summer’s COVID-19 wave may have reached its peak in some parts of the country, as major metrics report disease levels stagnating or starting to decline as of early September.
Kiffen ist inzwischen mit vielen Auflagen für Erwachsene erlaubt. Zugleich wächst der Markt für Cannabis als Medikament stark. Der neue Minister will dem einen Riegel vorschieben.
